ACTRT1 and neoplasm: A recent study found that, mutations in the eRNA element of ACTRT1 in basal cell carcinoma can weaken the enhancer’s activity as well as the expression of ACTRT1, resulting in the aberrant activation of Hedgehog signaling and, consequently, the promotion of carcinogenesis and tumour development [20].